Linyi Wei

Title: Linyi Wei: Innovator in Antitumor Agents

Introduction

Linyi Wei is a notable inventor based in Chapel Hill, North Carolina. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His work is characterized by a focus on innovative compounds that have the potential to impact cancer treatment.

Latest Patents

Linyi Wei holds a patent for "Tylophorine analogs as antitumor agents." This patent describes compounds of Formula I, which are preferably subject to the proviso that either (a) R and R together form —O—CH(R)—O—, or (b) R and R together form —O—CH(R)—O—, wherein R is H, halo, or lower alkyl. The patent also covers pharmaceutical salts, formulations, and methods of using these compounds in the treatment of cancer.

Career Highlights

Linyi Wei is affiliated with the University of North Carolina at Chapel Hill, where he conducts research and develops innovative solutions in the pharmaceutical field. His work has garnered attention for its potential applications in cancer therapy.

Collaborations

Linyi Wei has collaborated with esteemed colleagues such as Kuo-Hsiung Lee and Kenneth F Bastow. These partnerships have contributed to the advancement of research in antitumor agents and have fostered a collaborative environment for innovation.

Conclusion

Linyi Wei's contributions to the field of pharmaceuticals, particularly through his patent on Tylophorine analogs, highlight his role as an innovator in cancer treatment. His work continues to inspire advancements in the development of effective antitumor agents.